Global DNA Sequencing: Research, Applied and Clinical Markets

The global market for DNA Sequencing should grow from $15.7 billion in 2021 to $37.7 billion by 2026, at compound annual growth rate (CAGR) of 19.1% for the period of 2021-2026.

Report Includes

• 85 tables
• An updated review of the global market for DNA sequencing technologies and their applications in research, applied and clinical segments
• Analyses of the global market trends, with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
• Estimation of the market size and market forecast for DNA sequencing industry, and corresponding market share analysis by delivered format, product type, end use segment, application, disease category, and geography
• Highlights of key market dynamics (DROs) for DNA sequencing, regulatory scenario, and impact of COVID-19 on the progress of this market
• Discussion of market opportunities for DNA sequencing, industry structure, applications and business considerations of sequencing technologies, along with ongoing dramatic changes in the structure of MedTech industry
• Review of the leading next-generation sequencing (NGS) technologies, emerging applications, and penetration of DNA sequencing-based diagnostics and research initiatives affecting the marketplace
• Patent analysis for novel sequencing technologies, latest developments, clinical trials, and potential markets for future developments
• Insight into the sequencing industry activities including major acquisitions and strategic alliances, competitive benchmarking of key sequencing industry participants and their growth strategies
• Market share analysis of the key companies of the industry and their detailed company profiles including Agilent Technologies, Becton, Dickinson and Co., Bio-Rad, Danaher Corp., Illumina Inc., Merck KGaA, Roche, and Thermo Fisher

The global sequencing market should grow from $10.7 billion in 2018 to $24.4 billion by 2023, with a compound annual growth rate (CAGR) of 18.0% for the period of 2018-2023.

Report Includes

• 27 data tables and 79 additional tables
• An overview of global market for DNA sequencing and discussion of applications in research, applied and clinical markets
• Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
• Description of sequencing markets by workflow, including sample preparation products; sequencing instruments and consumables; informatics; and sequencing services
• Coverage of Sanger and next-generation technologies in detail
• Detailed description of key sequencing research & development programs such as American Gut Consortium, BabySeq and Blood Profiling Atlas
• A look at the current trends and recent developments in the market
• Company profiles of the major players of the market, including 23Andme Inc., Mayo Medical Laboratories, Novogene Co. Ltd., Qiagen NV, Roche Holding AG, Thermo Fisher Scientific Inc. and Zhejiang Dian Diagnostics Co. Ltd.

The global market for sequencing products has grown to $5.9 billion in 2015 from $5.3 billion in 2014. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 18.7% from 2015 to 2020, reaching nearly $13.8 billion by 2020.

Report Includes

• An in-depth analysis of the sequencing industry, an important industry in life sciences with enormous market potential.
• Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
• Quantification of the DNA sequencing markets by product type, platform, customer type, value chain position, analysis type and geography.
• A look at substantial future growth opportunities for industry participants including consumer and diagnostic sequencing services, bioinformatics, sequence enrichment, benchtop NGS sequencers and consumables, and emerging sequencing instruments.
• Comprehensive discussion covering sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives.
• A relevant patent analysis.
• Profiles of major players in the sequencing industry.

The global market for sequencing products and services reached $3.5 billion in 2012. This market is expected to grow to nearly $4.5 billion in 2013 and nearly 11.7 billion in 2018, a compound annual growth rate (CAGR) of 21.2%.

Report Includes

• An overview of the global market for sequencing products and services.
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
• Quantification of the DNA sequencing markets by product type, platform, customer type,value chain position, analysis type and geography.
• A look at substantial future growth opportunities for industry participants including consumer and diagnostic sequencing services, bioinformatics, sequence enrichment, benchtop NGS sequencers and consumables, and emerging sequencing instruments.

The global market for sequencing products was nearly $3 billion in 2011, and it is forecast to grow at a compound annual growth rate (CAGR) of 17.5% to reach $6.6 billion by 2016.

• The worldwide market for sequencing products will grow from an estimated $1.3 billion in 2010 to more than $3.3 billion by 2015, a compound annual growth rate (CAGR) of 20.5% over the next 5 years.
• Life-science research and drug discovery and development applications represent the two largest markets for DNA sequencing revenues, accounting for an estimated $920.1 million in 2010.  These markets are forecast to grow at a compound annual growth rate (CAGR) of 13% to reach nearly $1.7 billion in 2015.
• Emerging applications, including personal genomics and clinical diagnostics, are forecast to account for $541.4 million by the year 2015, an increase from $15.5 million in 2010 representing a 103.5% compound annual growth rate (CAGR).

• The global DNA sequencing industry was worth $794.1 million in 2007. This is expected to reach $862.5 million in 2008 and $1.7 billion in 2013, a compound annual growth rate (CAGR) of 14.7%./li>
• Research and drug discovery/development generated global revenues of $600.4 million in 2007. This is expected to increase to $640.6 million in 2008 and $1.0 billion in 2013, for a CAGR of 9.7%.
• Commercial applications were valued at $193.6 million in 2007 and an estimated $218.8 million in 2008. This segment should reach $426.1 million in 2013, a CAGR of 14.3%.

• Projected sales for the worldwide DNA sequencing and proteomics markets are expected to rise at an AAGR (average annual growth rate) of 17.6% from $7.8 billion in 2004 to $17.5 billion in 2009.
• Drug discovery and healthcare currently are two of the largest market sectors, representing respectively, some 46% and 20% of revenues in 2004.
• The food and renewable resource sector will grow at a modest pace motivated by the production of genetically altered food products offering better nutritional benefits and lower product costs.
• The environment market sector has only begun to tap into the technology benefits and this basic research sector will grow given the possibility of new research fields that may emerge.